In the genetically determined disorders cystinuria and Hartnup disease, amino acid transport defects are present in both the small intestine and the kidney (2-4). It would seem logical that agents which alter kidney function may also affect the transporting ability of the small intestine. We have therefore studied the effect on intestinal transport (by means of in vitro intestinal preparations) of some of the drugs that inhibit renal tubular transport.
In the genetically determined disorders cystinuria and Hartnup disease, amino acid transport defects are present in both the small intestine and the kidney (2) (3) (4) . It would seem logical that agents which alter kidney function may also affect the transporting ability of the small intestine. We have therefore studied the effect on intestinal transport (by means of in vitro intestinal preparations) of some of the drugs that inhibit renal tubular transport.
Methods
Everted gut sacs were made from the small intestine of male golden hamsters weighing between 80 and 130 g (5) . The nonfasting animal was killed by a blow on the head. The small intestine was then isolated, washed in situ with pH 7.4 Krebs bicarbonate buffer, and removed by stripping off the mesentery. It was then everted, and three segments each weighing approximately 600 mg were constructed from the entire length of the bowel. The nonelectrolyte whose transport was to be studied was placed at varying concentrations in the buffer, and 1 ml of this fluid was placed inside the sac. The sac was then placed in an Erlenmeyer flask with 5 ml of buffer containing the nonelectrolyte at an identical concentration.
Potential inhibitors at several concentrations were added to the buffer as indicated. After being gassed with 95% 02 and 5% C02, the flasks were stoppered and placed in an oscillating water bath kept at 370 C and 50 vibrations per minute for 1 hour. Portions of the serosal and mucosal fluids were centrifuged and then analyzed for radioactivity in a liquid scintillation spectrometer. The radioactively labeled materials L-lysine-'C (UL),2 methyl-L-methionine-14C,2 2-uracil-14C,2 glucose-14C (UL) ,2 and 'Na,2 as well as L-lysine monohydrochloride,3 were obtained commercially. Ethacrynic acid [2,3- 
and chlorothiazide 4 were used as the pure powders.
Krebs bicarbonate buffer (pH 7.4; sodium, 147 mEq per L; chloride, 127 mEq per L; H2PO4, 1.1 mEq per L; and HCO3-, 25 mEq per L) with a potassium concentration of 6.1 mEq per L was used in all experiments unless otherwise indicated. In some experiments buffer was used with a potassium concentration of 16.1 mEq per L and a sodium concentration of 135 mEq per L; this is referred to as "high potassium" buffer. In other experiments potassium was removed from the buffer, and the sodium concentration was increased to 152 mEq per L; this is referred to as "potassium-free" buffer. Anion concentrations remained unchanged in all buffers.
Nonelectrolyte transport. Nonelectrolyte transport was expressed as the ratio of mucosal-to-serosal concentration. Per cent inhibition was determined by comparing the increase in counts in the serosal medium per gram of wet tissue weight to that of an equal number of control sacs. In each experiment the absorption of six sacs from two animals in the presence of a potential inhibitor was compared to that of an equal number of control sacs. Each result represents at least two separate experiments.
Water transport. Net movement of water into the serosal compartment was determined gravimetrically. All weighings were performed in an identical fashion. The initial weight of the serosal fluid was determined before incubation by subtracting the weight of the empty sac from the weight of the filled sac. The weight of the serosal volume after incubation was determined by weighing the filled sac and reweighing after thorough drainage. The difference between these two weights was a measure of the net change in the serosal water compartment. To express this as milligram per milligram of dry tissue weight, we dried the tissue at 1050 C overnight and reweighed it.
Net sodium movement. 'Na was utilized in an estimate of net sodium movement by subtracting the initial total counts in the serosal compartment from the final total counts in the serosal compartment. Total counts (Table II) . Water and 22Na absorption were also markedly impaired in the presence of 5 mM ethacrynic acid (Tables III and IV) . Inhibition of water absorption was also dependent on the dosage of ethacrynic acid. One-tenth mM ethacrynic acid had no effect; 0.5 mM acid significantly inhibited water absorption (Table III) .
A study of the importance of the concentration of potassium in the medium was made. At 0.5 mM ethacrynic acid, there was no effect on L-lysine absorption with a potassium concentration of 6.1 mEq per L (Figure 1 ). This is in contrast to a significant inhibition in a potassium-free medium. The mucosal-serosal concentration ratio in a potassium-free buffer without ethacrynic acid was 3.72 + 0.91 (not significantly different from that in 6.1 mEq per L potassium medium shown in Table I), and in the presence of 0.5 mM ethacrynic acid it was 2.34 + 0.52 (p < 0.001). An increased potassium concentration decreased the inhibition of 10-4 M L-lysine absorption by 5 mM ethacrynic acid; in Krebs-bicarbonate buffer (K = 6.1 mEq per L), L-lysine absorption was inhibited 80% by 5 mM ethacrynic acid, but in a high potassium buffer the inhibition by 5 mM ethacrynic acid was reduced to 62%.
Chlorothiazide. Two mM chlorothiazide did not significantly inhibit intestinal transport of L-methionine, L-lysine, glucose, or uracil (Table V) . Water and 22Na absorption were impaired in the presence of 2 mM chlorothiazide (Tables IV and VI) .
Probenecid. The intestinal transport of L-methionine and L-lysine was significantly inhibited by 5 mM probenecid (Table VII) . The inhibition of L-lysine and L-methionine transport by probenecid was dose related (Table VIII) . Water and 22Na absorption in the hamster small intestine was not impaired by the presence of 5 mM probenecid (Tables IV and VI ). The transport of glucose and uracil was decreased, but not significantly, by 5 mM probenecid.
Discussion
Ethacrynic acid is a potent diuretic agent that inhibits sodium and water reabsorption in the ascending limb of the loop of Henle (7). Ethacrynic acid has been demonstrated to inhibit renal sodium-potassium-dependent ATPase (8, 9) and to inhibit both sodium efflux from erythrocytes (10, 11) and sodium movement across the toad bladder (12) .
In the present study, ethacrynic acid also inhibited transport of sodium in sacs made from the small intestine of the golden hamster. The occurrence of this inhibition appears straightforward, although the mechanism (whether due to inhibition of ATPase or another phenomenon) is uncertain. Ouabain and oligomycin, drugs that inhibit sodium-potassium ATPase and the "sodium pump," also inhibit amino acid and sugar transport (13, 14) . Ethacrynic acid inhibited nonelectrolyte transport in a dose-related manner, prob- (15) . Chlorothiazide probably inhibits reabsorption of sodium in the distal tubules and also interferes with the transport of uric acid (16) . However, its ability to inhibit ATPase has not been demonstrated (8 In the present study we have demonstrated the ability of several drugs, whose primary and perhaps sole function had been thought to be on the renal tubules, to inhibit intestinal absorption. This strengthens the evidence that there are functional similarities in the transport systems in the kidney and the small intestine. Morphologically the kidney and the small intestine have at least one similarity. Microvilli are characteristic of the small intestine and many other absorptive surfaces and are also found in the proximal tubules of the kidney (18) . More recently, the site of amino acid reabsorption in the kidney has also been localized to the proximal tubules (19) . A further similarity is that defects in amino acid transport systems have been found in the small intestine as well as in the kidney in the genetically determined diseases, cystinuria and Hartnup disease (2-4).
These observations may have clinical pertinence to the cachexia seen in some patients with chronic congestive heart failure. In addition to the malabsorption usually attributed to tissue anoxia (20) , the cardiorenal drugs might also contribute to cardiac cachexia by inhibiting intestinal absorption. The diarrhea that infrequently occurs during ethacrynic acid therapy (21-23) may be a consequence of inhibition of ATPase activity and sodium transport as has been postulated for the cathartic action of cascara and other vegetable cathartics (24) and in the diarrhea of cholera (25) . We suggest that these observations provide further evidence of functional similarities between the kidney and the small intestine. The relationship of cardiorenal drugs to intestinal absorption was discussed.
